Is capecitabine a cost-effective adjuvant treatment of stage III colon cancer in Ontario?

被引：0
|
作者：
Orchard, M. C. [1 ]
Hoch, J. S. [1 ]
Alibhai, S. M. [1 ]
机构：
[1] Univ Toronto, Toronto, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.15024
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
15024
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Duration of Adjuvant Chemotherapy for Stage III Colon Cancer
    Grothey, A.
    Sobrero, A. F.
    Shields, A. F.
    Yoshino, T.
    Paul, J.
    Taieb, J.
    Souglakos, J.
    Shi, Q.
    Kerr, R.
    Labianca, R.
    Meyerhardt, J. A.
    Vernerey, D.
    Yamanaka, T.
    Boukovinas, I.
    Meyers, J. P.
    Renfro, L. A.
    Niedzwiecki, D.
    Watanabe, T.
    Torri, V.
    Saunders, M.
    Sargent, D. J.
    Andre, T.
    Iveson, T.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (13): : 1177 - 1188
  • [32] COST-EFFECTIVE MANAGEMENT OF COLON AND RECTAL-CANCER
    HEINE, JA
    ROTHENBERGER, DA
    WORLD JOURNAL OF SURGERY, 1991, 15 (05) : 597 - 604
  • [33] ADJUVANT THERAPY FOR STAGE-III COLON-CANCER - ECONOMICS RETURNS TO RESEARCH AND COST-EFFECTIVENESS OF TREATMENT
    BROWN, ML
    NAYFIELD, SG
    SHIBLEY, LM
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (06) : 424 - 430
  • [34] Adjuvant Chemotherapy for Stage II and III Colon Cancer Following Complete Resection: A Cancer Care Ontario Systematic Review
    Meyers, B. M.
    Cosby, R.
    Quereshy, F.
    Jonker, D.
    CLINICAL ONCOLOGY, 2017, 29 (07) : 459 - 465
  • [35] Cost-utility analysis of adjuvant chemotherapy in patients with stage III colon cancer in Thailand
    Lerdkiattikorn, Panattharin
    Chaikledkaew, Usa
    Lausoontornsiri, Wirote
    Chindavijak, Somjin
    Khuhaprema, Thirawud
    Tantai, Narisa
    Teerawattananon, Yot
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2015, 15 (04) : 687 - 700
  • [36] Cost-Effective Patient Selection for Adjuvant Therapy in Stage IIIA Melanoma
    Sondak, Vernon K.
    Messina, Jane L.
    Tarhini, Ahmad A.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2020, 231 (05) : 554 - +
  • [37] Prognostic impact of the number of administrations of oxaliplatin in the adjuvant treatment of stage III colon cancer
    Reis, J.
    Costa, I.
    Valente, A.
    Costa, M.
    Fernandes, C.
    Tavares, N.
    Sarmento, C.
    Caeiro, C.
    Barbosa, M.
    ANNALS OF ONCOLOGY, 2020, 31 : S102 - S102
  • [38] Is fluoropyrimidindes without oxaliplatin optimal for the adjuvant treatment of mainstream stage III colon cancer?
    Abali, H.
    Yavuz, S.
    Calikusu, Z.
    Seyrek, E.
    ANNALS OF ONCOLOGY, 2015, 26 (01) : 245 - 245
  • [39] Adjuvant FOLFOX treatment for stage III colon cancer: how many cycles are enough?
    Tsai, Yi-Jian
    Lin, Jen-Kou
    Chen, Wei-Shone
    Jiang, Jeng-Kai
    Teng, Hao-Wei
    Yen, Chueh-Chuan
    Lin, Tzu-Chen
    Yang, Shung-Haur
    SPRINGERPLUS, 2016, 5
  • [40] FOLFOX and FLOX Regimens for the Adjuvant Treatment of Resected Stage II and III Colon Cancer
    Sharif, Saima
    O'Connell, Michael J.
    Yothers, Greg
    Lopa, Samia
    Wolmark, Norman
    CANCER INVESTIGATION, 2008, 26 (09) : 956 - 963
12345